New antihyperglycemic medications have been proven to have cardiovascular (CV) and renal benefits in type 2 diabetes mellitus (T2DM); however, an evidence-based decision tree in specific clinical scenarios is lacking.

Systematic review and meta-analysis of randomized controlled trials (RCTs), with trial sequential analysis (TSA).…[Read more]